Growth signals Jayex operates in hospitals and healthcare with a recent leadership appointment in 2024 and annual report release in 2023, signaling ongoing governance activity and potential strategic initiatives that could drive demand for patient engagement and digital platform enhancements.

Public company traction As a listed ASX company (JTL) with revenue between one and ten million USD, Jayex may be seeking scalable, revenue-protective solutions and partnerships to support growth, reporting discipline, and investor-facing technology demonstrations.

Engagement platform The core offering is a single platform for patient engagement, presenting opportunities to upsell modules such as reach, messaging, scheduling, analytics, and integration with CRM and support tools.

Technology stack Current tech usage includes Google Ads, HubSpot Content Hub, WordPress, Zendesk, and Microsoft 365, indicating availability and openness to marketing automation, customer service solutions, and web/content integrations that can be paired with patient experience enhancements.

Strategic partnerships Past collaborations with LYPHE Group on cannabis solutions suggest a willingness to pursue joint ventures or ecosystem partnerships, opening avenues for co-developed patient engagement use cases and regional expansion in healthcare and related services.